Status:
COMPLETED
Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis
Lead Sponsor:
Glasgow Caledonian University
Collaborating Sponsors:
MS Society, UK
NHS Lanarkshire
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Virtual reality (VR) has reported benefits of engagement, immersion, and motivation in rehabilitation and has been proposed to be a solution for long-term engaging rehabilitation methods. However, the...
Detailed Description
The aim of this study is to investigate the feasibility of an eight-week intervention of co-produced virtual reality (VR) games delivered using the Oculus Quest for improving the upper limb function o...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of multiple sclerosis.
- Degree of self-reported hand or upper limb impairment which interferes with some activities of daily living (ADL) (e.g. dressing, eating, grooming).
- Objective upper limb impairment, in at least one hand, as determined by a Nine Hole Peg Test (see Section Outcome Measures) of 2 standard deviations of more above the published normative values depending on age and sex.
- Must be able to travel to a research site.
Exclusion
- If they have had a relapse in the last three months
- Subjective cognitive problems resulting in them being unable to use the equipment or participate in virtual reality.
- Visual problems such that they cannot see the visual display within the headset (this does not include participants who have glasses that are enough to correct eyesight issues)
- Have a current eye infection.
- Have any significant co-existing neurological or orthopaedic conditions affecting the upper limb.
- Are unable to understand verbal or written explanations of the study or are unable to speak or understand English.
- Individuals who are currently enrolled in any clinical trials will be excluded, but those who have previously taken part in research and other trials will be eligible.
Key Trial Info
Start Date :
June 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 28 2023
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05320237
Start Date
June 26 2022
End Date
April 28 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amy Webster
Glasgow, Scotland, United Kingdom, G4 0BA